Literature DB >> 20356783

Rheumatic heart disease in indigenous populations.

Harvey White1, Warren Walsh, Alex Brown, Tania Riddell, Andrew Tonkin, Richmond Jeremy, David Brieger, Chris Zeitz, Leonard Kritharides.   

Abstract

Rates of acute rheumatic fever and chronic rheumatic heart disease in Aboriginal people, Torres Strait Islanders and Māori continue to be unacceptably high. The impact of rheumatic heart disease is inequitable on these populations as compared with other Australians and New Zealanders. The associated cardiac morbidity, including the development of rheumatic valve disease, and cardiomyopathy, with possible sequelae of heart failure, development of atrial fibrillation, systemic embolism, transient ischaemic attacks, strokes, endocarditis, the need for interventions including cardiac surgery, and impaired quality of life, and shortened life expectancy, has major implications for the individual. The adverse health and social effects may significantly limit education and employment opportunities and increase dependency on welfare. Additionally there may be major adverse impacts on family and community life. The costs in financial terms and missed opportunities, including wasted young lives, are substantial. Prevention of acute rheumatic fever is dependent on the timely diagnosis and treatment of sore throats and skin infections in high-risk groups. Both Australia and New Zealand have registries for acute rheumatic fever but paradoxically neither includes all cases of chronic rheumatic heart disease many of whom would benefit from close surveillance and follow-up. In New Zealand and some Australian States there are programs to give secondary prophylaxis with penicillin, but these are not universal. Surgical outcomes for patients with rheumatic valvular disease are better for valve repair than for valve replacement. Special attention to the selection of the appropriate valve surgery and valve choice is required in pregnant women. It may be necessary to have designated surgical units managing Indigenous patients to ensure high rates of surgical repair rather than valve replacement. Surgical guidelines may be helpful. Long-term follow-up of the outcomes of surgery in Indigenous patients with rheumatic heart disease is required. Underpinning these strategies is the need to improve poverty, housing, education and employment. Cultural empathy with mutual trust and respect is essential. Involvement of Indigenous people in decision making, design, and implementation of primary and secondary prevention programs, is mandatory to reduce the unacceptably high rates of rheumatic heart disease. Copyright 2010 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20356783     DOI: 10.1016/j.hlc.2010.02.019

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  18 in total

1.  Pathway out of poverty: a values-based college-community partnership to improve long-term outcomes of underrepresented students.

Authors:  Jamie Kamailani Boyd; Sharmayne A Kuuleialoha Kamaka; Kathryn L Braun
Journal:  Prog Community Health Partnersh       Date:  2012

2.  Treatment of trivalvular rheumatic heart disease: why it matters where we live.

Authors:  Mairead Christine Kelly; Robert Jennings; Matthew Heron
Journal:  BMJ Case Rep       Date:  2014-03-17

3.  Patient selection for ambulatory cardiac monitoring in the Indian healthcare environment.

Authors:  Maneesh Shrivastav; Rajendra Shrivastav; Jitendra Makkar; Mauro Biffi
Journal:  Heart Asia       Date:  2013-01-27

Review 4.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

5.  Partnership for sustainability in cardiac surgery to address critical rheumatic heart disease in sub-Saharan Africa: the experience from Rwanda.

Authors:  JaBaris D Swain; Daniel N Pugliese; Joseph Mucumbitsi; Emmanuel K Rusingiza; Nathan Ruhamya; Abel Kagame; Gapira Ganza; Patricia C Come; Suellen Breakey; Bonnie Greenwood; Jochen D Muehlschlegel; Cecilia Patton-Bolman; Agnes Binagwaho; R Morton Bolman
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

6.  Outcomes after mitral valve surgery for rheumatic heart disease.

Authors:  E Anne Russell; Warren F Walsh; Christopher M Reid; Lavinia Tran; Alex Brown; Jayme S Bennetts; Robert A Baker; Robert Tam; Graeme P Maguire
Journal:  Heart Asia       Date:  2017-06-19

Review 7.  Contributions of risk factors and medical care to cardiovascular mortality trends.

Authors:  Majid Ezzati; Ziad Obermeyer; Ioanna Tzoulaki; Bongani M Mayosi; Paul Elliott; David A Leon
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

8.  A review of outcome following valve surgery for rheumatic heart disease in Australia.

Authors:  E Anne Russell; Lavinia Tran; Robert A Baker; Jayme S Bennetts; Alex Brown; Christopher M Reid; Robert Tam; Warren F Walsh; Graeme P Maguire
Journal:  BMC Cardiovasc Disord       Date:  2015-09-23       Impact factor: 2.298

9.  Disparities in healthcare utilisation rates for Aboriginal and non-Aboriginal Albertan residents, 1997-2006: a population database study.

Authors:  Helen Chung; Ming Ye; Chris Hanson; Oluwaseun Oladokun; Michael J Campbell; Gordon Kramer; Ordan J Lehmann
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

10.  Northern Territory Heart Failure Initiative-Clinical Audit (NTHFI-CA)-a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale.

Authors:  Pupalan Iyngkaran; Jeff Tinsley; David Smith; Mark Haste; Kangaharan Nadarajan; Marcus Ilton; Malcolm Battersby; Simon Stewart; Alex Brown
Journal:  BMJ Open       Date:  2014-01-29       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.